Positive Pre-Clinical Results for Non-Alcoholic Steatohepatitis (NASH) with Anti-fibrotic DS102 Bioactive Lipid DUBLIN, Ireland, Jan. 5, 2015 (GLOBE NEWSWIRE) -- via PRWEB - DS102 was tested in an In Vivo Efficacy STAM™ model, an indication specific standard for NASH, over two different time periods, all...

DS107G-01 - Successful Completion of Phase I Oral DGLA Clinical Trial DUBLIN, Ireland, July 30, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Dignity Sciences Limited, a privately held biopharmaceutical company, today announced the successful completion of a Phase I trial with...

DS107E-02 - Positive Phase II Results in Atopic Dermatitis DUBLIN, Ireland, July 8, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Dignity Sciences Limited, a privately held biopharmaceutical company, today announced positive Phase II results for DS107E (DGLA cream),...